GlassScriptPhysician profile
Briana Garcia
NPI 1689836025
$938.07
in general payments reported to CMS, 2019-2025
15 companies · $69.59 in 2025
The $69.59 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.50 · 2020: $145 · 2021: $118 · 2022: $49.36 · 2023: $178 · 2024: $340 · 2025: $69.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302 · Travel and Lodging: $196 · Consulting Fee: $90.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.88 |
| Travel and Lodging | $195.99 |
| Consulting Fee | $90.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $195.99 | 2024 | Cardiomems |
| Amgen INC. | $134.12 | 2019-2024 | Otezla, Repatha |
| Novo Nordisk INC | $113.74 | 2019-2024 | Wegovy |
| Glaxosmithkline, LLC. | $91.51 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Ceribell, INC. | $90.32 | 2023 | Ceribell Rapid Response Eeg |
| Lilly USA, LLC | $81.02 | 2020-2022 | |
| Amarin Pharma, INC. | $50.84 | 2020-2022 | |
| Insulet Corporation | $39.29 | 2023-2024 | Omnipod |
| Vertex Pharmaceuticals Incorporated | $31.09 | 2025 | |
| Pacira Therapeutics, INC. | $22.03 | 2020 | |
| Novartis Pharmaceuticals Corporation | $20.73 | 2025 | |
| Dexcom, INC. | $20.01 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $17.77 | 2025 | Capvaxive, Gardasil 9 |
| Alexion Pharmaceuticals, INC. | $14.99 | 2021 | |
| Gilead Sciences, INC. | $14.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Briana Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.